Advanced search
Start date

Benedito Barraviera

CV Lattes ResearcherID ORCID

Universidade Estadual Paulista (UNESP). Campus de Botucatu. Centro Virtual de Toxinologia. Centro de Estudos de Venenos e Animais Peçonhentos (CEVAP)  (Institutional affiliation from the last research proposal)
Birthplace: Brazil

Under graduated in Medicine from Botucatu Medical School of São Paulo State University - UNESP (1977), Brazil, specialized in Tropical Medicine by the School of Medicine of University of São Paulo (1979), Master (MSc 1984) and Doctor (Ph.D. 1986) in Internal Medicine by UNESP. He was an Associate (1993) and now is a Full Professor (1999) of Infectious Diseases at Botucatu Medical School UNESP, São Paulo, Brazil. Now he is a Researcher at The Center for the Study of Venoms and Venomous Animals at UNESP (CEVAP), Emeritus Editor of The Journal of Venomous Animals and Toxins including Tropical Diseases ( Impact Factor Web of Science, JCR 2020 =2.831, CiteScore Scopus 2020 = 4,10, Cites/Doc Scopus 2020 = 2.710, First quartile (Q1) at Animal Science and Zoology, and Full Professor at Botucatu Medical School UNESP. He has experience in Toxinology, Tropical Medicine, Clinical Research, and Scientific Publishing working mainly in the following Disciplines: Infectious and Parasitic Diseases, Toxinology (envenomations by venomous animals), Clinical Research (clinical trials), Scientific writing, and publishing. Founder and Director of The Center for the Study of Venoms and Venomous Animals at UNESP (CEVAP), (Director in 1993-1997, 2006-2014, and 2018-2021), Pro-Dean of University Extension (2001-2004), and President of the Brazilian Association of Scientific Editors - ABEC (2008- 2012). From 2005 he became coordinator of the Research Group on Toxinology certified by UNESP and CNPq. From 2014 approved and became deputy coordinator of the National Institute of Science and Technology of Wildlife Science Center (WSC), CNPq 465429/2014-9. Until 2021 he coordinated two clinical trials phase I/II named respectively: Use of the heterologous fibrin sealant in the treatment of chronic venous ulcers and, Use of the new apilic antivenom to treat massive Africanized honeybee (Apis mellifera) attacks. Both biopharmaceuticals have been in development for more than 20 years in partnership with Vital Brazil Institute of Rio de Janeiro (RJ), Brazil. In 2018, the Ministry of Health approved the construction of the Biopharmaceuticals Samples Factory for Clinical Trials at CEVAP-UNESP. The agreement 873706/2018 was established between Caixa Econômica Federal and UNESP, and the construction will begin in 2022. In 2019, he was appointed as a Full Member of the Brazilian Academy of Pharmaceutical Sciences and in 2021 as a Correspondiente Extranjero de la Real Academia Nacional de Farmacia de España. In 2021 he became a Fellow Researcher (PQ-2) of the Brazilian National Council for Scientific and Technological Development (CNPq Proc. No. 306339/2020-0) and in 2022 approved the Center for Translational Science and Biopharmaceuticals Development, supported by The São Paulo Research Foundation (FAPESP Proc. No. 2021/11936-3), in partnership with other six research institutions in Brazil. ORCID (Source: Lattes Curriculum)

Articles published in Pesquisa para Inovação FAPESP about the researcher:
Startup develops alternative treatment for atopic dermatitis 
New research center aims to fill key gap for advancement of biotechnology in Brazil 
News published in Agência FAPESP Newsletter about the researcher
Articles published in other media outlets (0 total):
More itemsLess items
Research grants
Scholarships in Brazil
Scholarships abroad
FAPESP support in numbers * Updated June 15, 2024
Total / Available in English
Most frequent collaborators in research granted by FAPESP
Contact researcher

Service temporarily unavailable

Keywords used by the researcher
Please report errors in researcher information using this form.

Report errors in this page

Error details: